Uterine Dyskinesia (Clinical Trials)
Drug for Abnormal Contractions Enters Phase II Trials
Published in Women's Health Weekly, June 15th, 1998
This product is intended to relax the uterus and prevent uterine dyskinesia (abnormal contractions) and therefore may be useful in the treatment of disorders such as dysmenorrhea, difficult and painful menstruation; and for the treatment and prevention of endometriosis, the growth of endometrial tissue outside the uterus. Dysmenorrhea is a disorder afflicting nearly 25 million women in the U.S. -- more than 30 percent of all menstruating women. Endometriosis...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Substance Abuse
Report Calls Substance Abuse, Addiction by Older Women "Epidemic" - Smoking (Pregnancy)
Evidence of Huge Damage From Maternal Smoking Ignored - Breast Cancer (Clinical Trials)
Three New Trials Seeking Participants - Breast Cancer (Diagnosis)
Delayed Diagnosis in African-American Women - Bulimia Nervosa (Risk Factors)
Too Much Exercise May Put Some Young Women at Risk - Contraception (Risk Factors)
Long Period of Actinomyces Colonization Can Precede Invasive Infection in IUD Users - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
